Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Treg
Research
Antibody therapies could penetrate pancreatic cancer's shield
New research in mice has shed light on how antibodies could be harnessed to puncture the shield of scarlike cells that protect pancreatic cancer.
James Waldron
May 9, 2022 3:30pm
Lilly, Bayer, Merck catch classical buzz with $55M for Mozart Tx
Oct 26, 2021 10:22am
Metabolic signaling points to new targets in autoimmune diseases
Nov 18, 2020 8:44am
Treating diabetes by silencing IL-2's inflammatory power
Aug 14, 2020 2:00pm
Avoiding transplant rejection by learning from cancer
Mar 13, 2020 2:00pm
Roche pays €70M upfront for Tusk’s preclinical Treg depleter
Sep 28, 2018 7:33am
